SPINELLA, AMELIA
 Distribuzione geografica
Continente #
NA - Nord America 5.206
EU - Europa 2.447
AS - Asia 1.136
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 9
AF - Africa 8
Totale 8.837
Nazione #
US - Stati Uniti d'America 5.162
IT - Italia 727
GB - Regno Unito 592
SG - Singapore 381
SE - Svezia 374
CN - Cina 309
DE - Germania 281
HK - Hong Kong 174
FR - Francia 102
FI - Finlandia 101
TR - Turchia 84
UA - Ucraina 71
BG - Bulgaria 68
ID - Indonesia 48
IN - India 36
CA - Canada 35
IE - Irlanda 21
MY - Malesia 21
JP - Giappone 20
BE - Belgio 16
VN - Vietnam 16
LT - Lituania 14
BR - Brasile 13
CZ - Repubblica Ceca 13
NL - Olanda 13
RU - Federazione Russa 13
IR - Iran 12
KR - Corea 10
ES - Italia 8
EU - Europa 8
RO - Romania 8
AU - Australia 7
BZ - Belize 6
IL - Israele 5
PK - Pakistan 5
ZA - Sudafrica 5
CL - Cile 4
IQ - Iraq 4
PL - Polonia 4
RS - Serbia 4
TW - Taiwan 4
AT - Austria 3
HU - Ungheria 3
TH - Thailandia 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BD - Bangladesh 2
BY - Bielorussia 2
CH - Svizzera 2
LU - Lussemburgo 2
MX - Messico 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AL - Albania 1
CO - Colombia 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 8.837
Città #
Fairfield 669
Chandler 592
Santa Clara 472
Southend 470
Ashburn 373
Woodbridge 321
Singapore 290
Houston 288
Nyköping 266
Seattle 256
Wilmington 218
Cambridge 199
Hong Kong 171
Jacksonville 142
Ann Arbor 140
Dearborn 132
San Diego 123
Helsinki 86
Bologna 79
Princeton 71
Bremen 69
Sofia 68
Modena 65
New York 65
Milan 64
Beijing 52
Izmir 49
Jakarta 48
Shanghai 40
Atlanta 33
London 33
Redwood City 32
Frankfurt am Main 29
Eugene 28
Parma 27
Munich 20
Ottawa 20
Florence 18
Falls Church 17
Brussels 16
Rome 16
Reggio Emilia 13
Los Angeles 12
Boardman 11
Grafing 11
Guangzhou 11
Nanjing 11
San Jose 11
Antalya 10
Dong Ket 10
Dublin 10
Napoli 10
Ruston 10
Tokyo 10
Brno 9
Norwalk 9
San Mateo 8
Toronto 8
Brescia 7
Chicago 7
Kunming 7
Pune 7
Belize City 6
Chengdu 6
Dallas 6
Hefei 6
Padova 6
Serra San Bruno 6
Tehran 6
Vicenza 6
Fremont 5
Grosseto 5
Hounslow 5
Johannesburg 5
Kilburn 5
Naples 5
Philadelphia 5
São Paulo 5
Washington 5
Boston 4
Castelfranco Emilia 4
Castenaso 4
Cesena 4
Columbus 4
Duncan 4
Formigine 4
Genova 4
Ho Chi Minh City 4
Paris 4
Saint Louis 4
San Francisco 4
Sorbolo 4
Treviso 4
Tulare 4
Augusta 3
Ballybofey 3
Casalgrande 3
Castel San Giovanni 3
Castelfranco di Sotto 3
Chiswick 3
Totale 6.540
Nome #
Systemic sclerosis progression INvestiGation (SPRING) Italian registry: Demographic and clinico-serological features of the scleroderma spectrum 251
COVID-19 and rheumatic autoimmune systemic diseases: report of a large Italian patients series 246
Elevated Troponin Serum Levels in Adult Onset Still's Disease 231
The discrepancy between clinical and ultrasonographic remission in rheumatoid arthritis is not related to therapy or autoantibody status. 224
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 213
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 210
Large Vessel Vasculitis Occurring in Rheumatoid Arthritis Patient under Anti-TNF Therapy 204
Cardiac involvement in systemic sclerosis: identification of high-risk patient profiles in different patterns of clinical presentation 192
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 191
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 190
Systemic sclerosis evolution of disease pathomorphosis and survival. Our experience on Italian patients' population and review of the literature 187
Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 182
Efficacy of Belimumab for active lupus nephritis in a young Hispanic woman intolerant to standard treatment: a case report 175
Ultrasonography involvement of carotid, upper and lower limb arteries in a large cohort of systemic sclerosis patients 169
The profiling of axial spondyloarthritis patient candidate to a biologic therapy: Consensus from a Delphi-panel of Italian experts 166
Management of cardiopulmonary disease in patients with systemic sclerosis: cardiorheumatology clinic and patient care standardization proposal 164
The safety of iloprost in systemic sclerosis in a real-life experience 162
Cryoglobulin evaluation: analysis of intra-laboratory and inter-laboratory variability 162
Beyond cat scratch disease: a case report of bartonella infection mimicking vasculitic disorder 158
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 158
Procedural pain management in the treatment of scleroderma digital ulcers 156
Use of Neem oil and Hypericum perforatum for treatment of calcinosis-related skin ulcers in systemic sclerosis 151
COVID-19 in Italian patients with rheumatic autoimmune systemic diseases 144
PREVALENCE OF ULTRASOUND ABNORMALITIES IN PATIENTS WITH PSORIATIC ARTHRITIS IN A CLINICAL PHASE OF MINIMAL DISEASE ACTIVITY UNDER ANTI-TNF TREATMENT 139
The prevalence of asymptomatic early sacroiliitis in Crohn’s disease patients: The single experience of an Italian tertiary care centre 138
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 134
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 134
Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 133
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 131
DANCE CLASS DEDICATED TO SCLERODERMA PATIENTS: JOINT EVALUATION, FUNCTIONAL AND QUALITY OF LIFE BEFORE AND AFTER TREATMENT – CLINICAL TRIAL 128
Impegno cardiaco nella sclerosi sistemica 128
Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study 125
Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 122
Living with arthritis: a “training camp” for coping with stressful events? A survey on resilience of arthritis patients following the COVID-19 pandemic 122
DIGITAL NECROSIS IN SYSTEMIC SCLEROSIS NOT ONLY A MICROVASCULAR DISEASE: A CASE REPORT 121
SEVERE VITAMIN D DEFICIENCY IN SYSTEMIC SCLEROSIS 117
Photobiomodulation Therapy: A New Light in the Treatment of Systemic Sclerosis Skin Ulcers 114
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 112
Autologous fat grafting in the treatment of a scleroderma stump-skin ulcer: a case report 108
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 107
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 103
IS THERE A DISSOCIATION BETWEEN CLINICAL REMISSION AND ULTRASONOGRAPHIC ASSESSMENT IN RHEUMATOID ARTHRITIS? 98
Invited Response on: Comments on "Autologous Fat Grafting for the Oral and Digital Complications of Systemic Sclerosis: Results of a Prospective Study" 92
Covid-19 vaccine hesitancy in systemic sclerosis 91
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 88
Resilience of systemic sclerosis patients following the first COVID-19 wave in Italy 88
AB0724 Cardio-pulmonary disease management in patients with systemic sclerosis: cardio-rheumatology clinic and patient care standardisation proposal 84
AB0760 Advanced oxidation protein products in serum of patients with systemic sclerosis: a possible indicator of clinical evolution 83
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 82
AB0212 LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSISMANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 82
AB0645 CANNABINOIDS IN THE TREATMENT OF PAIN RELATED TO SYSTEMIC SCLEROSIS SKIN ULCERS: OUR EXPERIENCE 81
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 78
AB0611 STRAIN ANALYSIS OF THE RIGHT VENTRICLE USING 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN A COHORT OF PATIENTS WITH SYSTEMIC SCLEROSIS 78
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 76
Management of Systemic Sclerosis Patients in the COVID-19 Era: The Experience of an Expert Specialist Reference Center 75
Thu0349 autologous fat grafting in the treatment of patients with systemic sclerosis: current experience and future prospects 75
POS0837 THE USE OF CANNABIDIOL IN THE TREATMENT OF PAIN RELATED TO SCLERODERMA DIGITAL ULCERS 72
Letters to the Editors 70
SAT0285 EVALUATION OF CHRONIC PAIN IN PATIENTS WITH SYSTEMIC SCLEROSIS COMPARED TO THOSE WITH CHRONIC HEADACHE AND RHEUMATOID ARTHRITIS 69
Erratum to "From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution" 68
Organic-inorganic materials through first simultaneous frontal polymerization and frontal geopolymerization 68
THU0600 a case of systemic sclerosis complicated by renal crisis: potential etiopathogenetic role of cytomegalovirus and treatment 68
Systemic sclerosis cutaneous expression: Management of skin fibrosis and digital ulcers 67
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients’ subgroups 66
FRI0442 Long-term treatment with rituximab in interstitial lung disease related to systemic sclerosis: our clinical experience 61
Pulmonary arterial hypertension: Guidelines and unmet clinical needs 57
Infections of scleroderma digital ulcers: A single center cohort retrospective study 56
One-year clinical experience on the use of Nintedanib in Systemic Sclerosis 52
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 47
Peripheral Microangiopathy Changes in Pulmonary Arterial Hypertension Related to Systemic Sclerosis: Data From a Multicenter Observational Study 38
OP0063 QUANTITATIVE COMPUTED TOMOGRAPHY PREDICTS 10-YEAR MORTALITY IN INTERSTITIAL LUNG DISEASE RELATED TO SYSTEMIC SCLEROSI 38
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 30
Cryoproteinemia: new frontiers for clinicians and the laboratory 30
Cryofibrinogen: A possibile risk factor in systemic sclerosis 29
From Raynaud Phenomenon to Systemic Sclerosis in COVID-19: A Case Report 27
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 26
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 25
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 24
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 21
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 17
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 17
L’IPERTENSIONE POLMONARE: DALLE NUOVE LINEE GUIDA ALLA PRATICA CLINICA 16
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 15
Real life use of prostacyclin analog (Iloprost), a multi-centric survey data from the scleroderma study group Emilia Romagna (Sclero-RER) and review of the literature 15
Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis 13
The importance of body image and aesthetic medicine in systemic sclerosis 12
JANUS KINASES INHIBITORS IN CLINICAL PRACTICE IN ITALY. RESULTS FROM A SINGLE CENTER EXPERIENCE 12
Residual inflammation in psoriatic arthritis patients in stable minimal disease activity 11
Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study 10
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 10
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 9
Totale 9.019
Categoria #
all - tutte 44.919
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.919


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020795 0 0 0 0 91 180 182 126 97 29 57 33
2020/20211.533 89 43 60 83 97 99 496 142 127 82 149 66
2021/20221.565 86 64 109 127 75 130 45 108 175 136 326 184
2022/20231.671 216 207 116 147 205 210 69 151 220 25 53 52
2023/20241.162 42 69 52 168 204 91 91 111 31 40 98 165
2024/20251.169 139 77 91 311 551 0 0 0 0 0 0 0
Totale 9.019